News > Sputnik V hits production roadblock for second dose of Covid vaccine

Sputnik V hits production roadblock for second dose of Covid vaccine

Russia’s Sputnik V has reportedly hit a roadblock in the development of the second dose of its Covid-19 vaccine in India. Sources in the government have said that the Russian vaccine maker is facing manufacturing issues with producing the second component (AD5) of the adenovirus vector-based vaccine.

The development of the second shot of Sputnik V vaccine has hit a technical roadblock, this may result in a delay in adding more doses to India’s vaccination targets.